Tezcan Gecgil

Tezcan Gecgil

InvestorPlace Contributor

Expertise: ETFs, Options Trading, Technical and Fundamental Analysis

Education: PhD (Business Studies), MSc (Investment Banking & Trading), MBA

Awards & Accomplishments: Completed all 3 levels of the Chartered Market Technician (CMT) qualification

About Tezcan
Tezcan Gecgil, PhD, began contributing to InvestorPlace in 2018. She has worked in investment management in the U.S. and U.K., including a Greenwich, Connecticut-based hedge fund as well as the American Stock Exchange, CFA Institute, and Bloomberg. She has also taught at various U.S. and U.K. universities.

She holds Ph.D. (Business Studies) as well as MSc (Investment Banking & Trading) and MBA degrees from leading U.S. and U.K. universities and has also completed all three levels of the Chartered Market Technician (CMT) examination.

Her passion is for options trading based on technical analysis of fundamentally strong companies. She especially enjoys setting up weekly covered calls for income generation. Publicly, she has also contributed to investing.com and the U.K. website of The Motley Fool. She is also part of the investment management writing team at Copylab.

When not navigating the markets, Tezcan delves into the mysteries of history and explores new destinations.

Recent Articles

7 Companies to Invest in That Pivoted Perfectly in the Pandemic

By Tezcan Gecgil, InvestorPlace Contributor

The novel coronavirus pandemic produced some clear winners. And here are seven companies to invest in that adjusted well to the "new normal."

The Top 3 Stocks To Buy If We Enter A Deeper Correction

By Tezcan Gecgil, InvestorPlace Contributor

Buying great businesses at a discount while markets plunge helps long-term portfolios. So here are three top stocks to buy this fall.

Pfizer Shares May Catch Momentum Soon From Vaccine Work

By Tezcan Gecgil, InvestorPlace Contributor

PFE's dividend yield as well as prospects for a Covid-19 vaccine should put Pfizer stock on the radar of long-term investors.

What Will It Take to Push Norwegian Cruise Line Stock Back to $60?

By Tezcan Gecgil, InvestorPlace Contributor

Unless sailing begin soon, the fate of Norwegian Cruise Line stock may depend on the operator's ability to raise more cash.

Workhorse Group Shares Are Overvalued, But Catalysts May Lift Its Stock Further

By Tezcan Gecgil, InvestorPlace Contributor

Short-term traders with gains in WKHS stock may want to take money off the table

3 Sports Stocks Robinhood Investors Are Buying

By Tezcan Gecgil, InvestorPlace Contributor

Here are three sports stocks to buy that have the potential to help you strengthen both your muscles and long-term portfolios.

4 Biotech Stocks to Buy for Big Gains in 2020

By Tezcan Gecgil, InvestorPlace Contributor

The novel coronavirus is weighing on the market, but these four biotech stocks can survive. Here's what you need to know to profit now.

Volatile Jumia Technologies Stock Will Stay That Way for a While

By Tezcan Gecgil, InvestorPlace Contributor

Share in the African e-commerce company has been hot this year. But JMIA stock is likely to see $5 before $10.

BioNTech Investor Fortunes Rise and Fall on Headlines, Pacts and Funding

By Tezcan Gecgil, InvestorPlace Contributor

BNTX stock is a high-risk high-return investment. BioNTech shares will likely to range-trade in the short run.

Will EV Momentum Carry DiamondPeak Stock in September, Too?

By Tezcan Gecgil, InvestorPlace Contributor

DiamondPeak stock has skyrocketed following the announcement of a SPAC reverse merger. But the run-up may be about to come to an end soon

Load More